HCA Healthcare (HCA +1.04%), an operator of healthcare facilities, released its fourth-quarter earnings for the year 2024 on January 24. In the report, it revealed a revenue total of $18.285 billion, surpassing analyst estimates of $18.234 billion. However, the diluted earnings per share (EPS) were $5.63, which missed the expected $6.13. Notably, the quarter was challenging due to revenue losses linked to Hurricanes Helene and Milton. Despite these challenges, the company demonstrated solid operational growth, although impacted by labor cost pressures and natural disasters.
| Metric | Q4 2024 | Q4 Estimate | Q4 2023 | Y/Y Change |
|---|---|---|---|---|
| EPS | $5.63 | $6.13 | $5.93 | -5.1% |
| Revenue | $18.285B | $18.234B | $17.303B | +5.7% |
| Adjusted EBITDA | $3.712B | N/A | $3.618B | +2.6% |
| Net Income | $1.438B | N/A | $1.607B | -10.5% |
Source: Analyst estimates for the quarter provided by FactSet.
Overview of HCA Healthcare
HCA Healthcare is a major player in the American healthcare sector, operating numerous hospitals and outpatient centers. With roots dating back decades, it has expanded to provide a variety of healthcare services across the United States and substantial operations in England. Its key competitive advantages lie in revenue diversification, strong market positioning, and strategic expansions.
The company identified vital areas including regulatory compliance and labor management as significant to its success. With changes in regulatory environments and labor dynamics, HCA Healthcare's strategies have been centered on enhancing revenue streams and managing costs effectively.
NYSE: HCA
Key Data Points
Quarter Highlights
During Q4 2024, HCA Healthcare achieved revenue of $18.285 billion, surpassing expectations despite environmental disruptions. Hurricanes Helene and Milton led to revenue losses estimated at $200 million, heavily impacting facilities in North Carolina and Florida. These natural disasters contributed significantly to the missed Earnings Per Share (EPS) targets as they detracted $0.60 per share.
Operationally, the company saw a 3.0% increase in same-facility admissions alongside a 2.8% growth in inpatient surgeries, indicating robust demand for healthcare services despite the challenges. Emergency room visits rose by 2.4%, underscoring increased patient interactions and a higher engagement level compared to outpatient facilities, which saw a 1.3% decline in surgeries.
From a financial perspective, HCA's operating cash flow was reported at $2.559 billion, highlighting its strong ability to generate cash despite the external hurdles. The quarter also witnessed a continuation of its share repurchase strategy, with 4.739 million shares bought back for $1.7 billion.
Looking Ahead
For 2025, HCA Healthcare projects its revenue to range from $72.8 billion to $75.8 billion. EPS is expected to be between $24.05 and $25.85, pointing toward anticipated steadiness and financial resilience. Key strategies include investments in AI and digital technologies aimed at enhancing operational outputs and patient care.
The focus remains on expanding infrastructure, including new inpatient and outpatient facilities, and refining operational practices to adapt to evolving healthcare regulations. Investors should monitor the company's success in navigating regulatory changes and workforce management.
